Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Use of unsedated endoscopy and propofol in practice

Unsedated endoscopy does not have a great impact on endoscopic screening in the US, although propofol sedation has gained acceptance in the community, finds the latest issue of Gastrointestinal Endoscopy.

News image

fiogf49gjkf04

There have been lower reimbursements for endoscopic procedures and increasing demand for screening endoscopy over the past decade.

This has spurred efforts to increase efficiency in the performance of endoscopic procedures.

Two dichotomous approaches have emerged, which include unsedated endoscopy and propofol sedation.

Dr Ashley Faulx and colleagues determined national practice patterns of unsedated endoscopy and propofol sedation.

45% do not routinely offer unsedated esophagogastroduodenoscopy and colonoscopy
Gastrointestinal Endoscopy

The researchers assessed endoscopists' attitudes toward unsedated screening with an electronic survey.

The research team developed a short survey, which was then converted to a Web-based format.

All national members of the American Society for Gastrointestinal Endoscopy were invited via electronic mail to participate.

The researchers collected survey data electronically.

The research team reported that 2 e-mails elicited responses to the Web survey from 18% of members contacted, within 2 weeks.

Of the respondents, the team found that 45% do not routinely offer unsedated esophagogastroduodenoscopy and colonoscopy.

The team also found that only 15% of those respondents planned to incorporate unsedated endoscopy into their practice in the next year.

Of the 55% who currently perform unsedated endoscopy, the team noted that 85% do no more than 25 unsedated procedures per year.

The researchers found that lack of patient acceptance was the most common reason cited for not offering unsedated endoscopy.

Most endoscopists felt that the availability of unsedated esophagoscopy would not significantly increase screening for Barrett's esophagus.

The team also noted that most endoscopists thought unsedated colonscopy would not increase screening for colonic polyps or colorectal cancer.

The team observed that 19% reported routine use of propofol sedation for esophagogastroduodenoscopy, and 22% routinely used colonoscopy.

The researchers reported that endoscopic retrograde cholangiopancreatography or endoscopic ultrasonography was routinely used by 19%.

Community practitioners were more likely to use propofol than those at academic centers.

Of those not currently using propofol, the team found that 43% plan to incorporate it into their practice within the next year.

In addition, the researchers noted that over 70% of respondents would themselves choose to be sedated for routine endoscopic procedures.

Dr Faulx's team concluded, “Electronic surveys allow for rapid distribution and data collection but suffer from a limited response rate.”

“The survey suggests that unsedated endoscopy has limited acceptance in the United States.”

“Without a major intervention that affects endoscopists' attitudes, its use is not likely to increase significantly.”

“Unsedated endoscopy will not have a great impact on endoscopic screening.”

“In contrast, propofol sedation has already gained acceptance in the community, and the routine use of propofol in endoscopy units will likely increase in the future.”

Gastrointest Endosc 2005: 62(1): 9
11 July 2005

Go to top of page Email this page Email this page to a colleague

 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 20 April 2018 
Two annexin A11 epitopes targeted by IgG1 and IgG4 autoantibodies were shared between patients with IAC/AIP and IgG4 antibodies blocked binding of IgG1 antibodies to the shared annexin A11 epitopes
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 19 April 2018 
c-Myc expression and pancreatic cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us